Logo

JYNT

The Joint Corp.

JYNT

The Joint Corp. NASDAQ
$8.42 -0.24% (-0.02)

Market Cap $127.99 M
52w High $13.47
52w Low $7.50
Dividend Yield 0%
P/E -842
Volume 55.37K
Outstanding Shares 15.20M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $13.381M $10.559M $855.009K 6.39% $0.06 $763.762K
Q2-2025 $13.27M $11.636M $93.363K 0.704% $0.006 $-714.313K
Q1-2025 $13.078M $10.784M $967.796K 7.4% $0.053 $-288.245K
Q4-2024 $-38.285M $-45.274M $-2.715M 7.092% $-0.18 $-1.194M
Q3-2024 $30.198M $30.561M $-3.165M -10.481% $-0.21 $1.859M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $30.713M $69.385M $46.664M $22.697M
Q2-2025 $29.812M $73.183M $49.922M $23.237M
Q1-2025 $21.918M $77.194M $57.256M $19.913M
Q4-2024 $25.051M $83.154M $62.476M $20.653M
Q3-2024 $20.738M $79.599M $59.123M $20.451M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $290.37K $1.773M $-317.84K $-1.741M $-286.22K $1.455M
Q2-2025 $93.363K $868.649K $7.233M $0 $8.102M $363.609K
Q1-2025 $801.43K $-3.701M $-291.405K $893.182K $-3.099M $-4.032M
Q4-2024 $-2.715M $4.13M $-104.253K $-24.861K $4.001M $3.846M
Q3-2024 $-3.165M $3.448M $-93.944K $-6.403K $3.348M $3.204M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Advertising
Advertising
$0 $0 $0 $0
Franchise
Franchise
$0 $0 $0 $0
Product and Service Other
Product and Service Other
$0 $0 $0 $0
Royalty
Royalty
$20.00M $10.00M $10.00M $10.00M
Technology Service
Technology Service
$0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Revenue climbed nicely through 2022, but then pulled back and has been roughly flat in the last two years. The business is still generating solid gross profit, but most of that is getting absorbed by operating costs, leaving operating income near breakeven. Profitability has clearly weakened: the company moved from healthy profits a few years ago to small losses more recently, and earnings per share have swung from strongly positive to meaningfully negative. Overall, the top line shows that the concept still has demand, but the bottom line tells a story of cost pressure, slower growth, and a business that needs to re‑earn its margins.


Balance Sheet

Balance Sheet The balance sheet looks relatively simple and lean, which fits an asset‑light, franchise‑heavy model. Total assets have been fairly stable over time, with no sign of aggressive expansion funded by borrowing. Cash levels, while not large, have improved versus a couple of years ago, and the company has essentially eliminated its debt, which reduces financial risk. Equity is positive but not large, suggesting a modest cushion against future losses. In short, the balance sheet is clean and de‑levered, but not especially thick with excess capital.


Cash Flow

Cash Flow Despite recent accounting losses, the company continues to generate positive cash from its core operations, and free cash flow has generally stayed in positive territory. Capital spending has been modest, reflecting a shift toward franchising rather than owning a lot of clinics outright. This helps keep cash needs manageable. The pattern suggests that, even in a tougher earnings period, the model still throws off some cash, though not at a level that would support very heavy investment or major new obligations without care.


Competitive Edge

Competitive Edge The Joint has a clear niche: convenient, retail‑style chiropractic care with walk‑in access, memberships, and a national brand. It is one of the largest and best‑known players in this specific format, which gives it scale advantages in marketing, technology, and franchisee support. The franchise model allows rapid geographic reach without tying up too much capital. On the flip side, the core service—chiropractic adjustments—is relatively easy for local competitors to offer, and success depends heavily on keeping franchisees profitable and patients loyal. Its edge rests on brand, convenience, and execution more than on unique clinical IP, which makes ongoing operational excellence and marketing critical.


Innovation and R&D

Innovation and R&D Innovation here is less about new medical procedures and more about business model and technology. The company has built proprietary systems for patient records and operations across hundreds of clinics, and it is leaning into digital tools like a mobile app, CRM upgrades, and data‑driven marketing. These efforts aim to make visits easier, increase repeat usage, and help franchisees run clinics more efficiently. There are also early moves toward using data and potentially AI to optimize performance, plus experiments with new pricing and potential add‑on wellness services. Formal R&D spending in the traditional sense is likely modest, but there is ongoing investment in process, software, and customer experience innovation that supports the franchise platform.


Summary

The Joint Corp. combines a disruptive, retail‑style chiropractic model with an asset‑light franchise strategy. Financially, it has shifted from profitable growth to a period of flat sales and operating losses, although cash generation remains positive and the balance sheet is cleaner with no debt. Its competitive strengths lie in brand scale, convenience, and a recurring membership approach, but margins have come under pressure and the service itself is not deeply differentiated clinically. The company is actively investing in technology and digital experience to deepen its moat and support a more “pure” franchisor model. Future performance will hinge on restoring profitability, keeping franchisees successful, and turning its tech and data advantages into better clinic economics and more loyal patients.